Company Profile
- Stock Code
- AMGN
- ISIN Code
- US0311621009
- Currency
- US Dollar (USD)
- IPO Date
- 1983-06-17

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease;...